Atlas Data Storage Selected to Present at TSMC Technology Symposium
Recognition Highlights Atlas' Leadership in CMOS-Enabled Molecular Technology
Atlas' invitation underscores the growing importance of CMOS-enabled molecular platforms. These next-generation solutions address enterprise IT challenges, such as molecular data storage—a necessity as artificial intelligence, enterprise workloads, and scientific discovery drive exponential data growth. Molecular data storage offers density and longevity several orders of magnitude greater than magnetic media, significantly lowering the total life-cycle cost of enterprise preservation.
"We are pleased to be selected by TSMC for its
At the symposium, Atlas will showcase its CMOS-enabled high-throughput molecular data preservation solution designed to address the limitations of conventional data storage media in terms of durability, density, carbon footprint, and data storage life cycle cost.
About Atlas Data Storage
Atlas Data Storage is pioneering the next era of digital preservation by commercializing synthetic DNA-based data storage. Optimized by nature for durability, density, and duplication, DNA is the ideal media to keep data safe -- forever. Atlas technology provides a low-maintenance and environmentally friendly solution to address the explosive growth of archival data. By fusing CMOS ASIC designs, molecular biology and advanced materials science, Atlas is redefining what's possible for data preservation and archival infrastructure.
To learn more about Atlas data preservation services, visit www.atlasds.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/atlas-data-storage-selected-to-present-at-tsmc-technology-symposium-302746453.html
SOURCE Atlas Data Storage
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genesis Automation Healthcare Adds Senior Leaders for Global Sales, Client Success, and Product Ahead of AHRMM26
- Decathlon Reaches 700 Stores Equipped with Vusion Solutions
- Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share